B R Smith

605 total citations
16 papers, 398 citations indexed

About

B R Smith is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, B R Smith has authored 16 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Infectious Diseases and 4 papers in Molecular Medicine. Recurrent topics in B R Smith's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). B R Smith is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). B R Smith collaborates with scholars based in United States, New Zealand and Australia. B R Smith's co-authors include Jack L. LeFrock, Mark A. Reddish, Andrew E. Warren, Joel Linden, Geoffrey P. Sharratt, James B. Dale, Louis Fries, Joanne M. Langley, Darlene Baxendale and Steven D. Stroop and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

B R Smith

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B R Smith United States	6	269	248	81	53	40	16	398
MarkR. Wallace United States	5	129 0.5×	85 0.3×	37 0.5×	65 1.2×	21 0.5×	5	256
I. Mohammédi France	11	205 0.8×	111 0.4×	99 1.2×	34 0.6×	33 0.8×	32	372
C Brandimarte Italy	8	114 0.4×	90 0.4×	97 1.2×	52 1.0×	26 0.7×	32	306
Ingrid K. Blomquist United States	7	200 0.7×	97 0.4×	172 2.1×	71 1.3×	102 2.5×	11	447
Eva Grahn Sweden	11	217 0.8×	286 1.2×	160 2.0×	24 0.5×	32 0.8×	16	434
Hila Shaked Israel	11	298 1.1×	137 0.6×	193 2.4×	31 0.6×	35 0.9×	16	419
Raymond Duperval Canada	12	169 0.6×	56 0.2×	222 2.7×	72 1.4×	14 0.3×	22	399
Natalia Jimenez‐Truque United States	11	177 0.7×	102 0.4×	87 1.1×	43 0.8×	68 1.7×	26	312
Claes Henning Sweden	11	93 0.3×	69 0.3×	131 1.6×	63 1.2×	10 0.3×	19	363
M. E. García-Leoni Spain	6	161 0.6×	55 0.2×	317 3.9×	54 1.0×	19 0.5×	6	393

Countries citing papers authored by B R Smith

Since Specialization

Citations

This map shows the geographic impact of B R Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B R Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B R Smith more than expected).

Fields of papers citing papers by B R Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B R Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B R Smith. The network helps show where B R Smith may publish in the future.

Co-authorship network of co-authors of B R Smith

This figure shows the co-authorship network connecting the top 25 collaborators of B R Smith. A scholar is included among the top collaborators of B R Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B R Smith. B R Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Smith, B R, et al.. (2025). Myeloperoxidase Enzyme Activity in Feces Reflects Endoscopic Severity in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(8). 2254–2268. 2 indexed citations

Brown, Stephanie, Laura Appleton, B R Smith, et al.. (2024). Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease. Inflammatory Bowel Diseases. 31(3). 800–811. 2 indexed citations

Sly, Peter D., Claire Wainwright, David W. Reid, et al.. (2024). Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis. Journal of Cystic Fibrosis. 23(6). 1163–1166. 1 indexed citations

McNeil, Shelly, Scott A. Halperin, Joanne M. Langley, et al.. (2005). Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers. Clinical Infectious Diseases. 41(8). 1114–1122. 232 indexed citations

Hoskins, Gaylor, et al.. (1997). Does participation in distance learning and audit improve the care of patients with acute asthma attacks? The General Practitioners in Asthma Group.. PubMed. 55(3). 150–5. 5 indexed citations

Smith, B R, et al.. (1986). Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Antimicrobial Agents and Chemotherapy. 29(2). 346–349. 2 indexed citations

Smith, B R, et al.. (1986). In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents. Antimicrobial Agents and Chemotherapy. 29(2). 355–358. 9 indexed citations

LeFrock, Jack L., B R Smith, Brendan G. Carr, & Jon T. Mader. (1985). Bone and joint infections caused by gram-positive bacteria: Treatment with cefotaxime. Infection. 13(S1). S50–S55. 10 indexed citations

LeFrock, Jack L. & B R Smith. (1985). Treatment of helminthic diseases.. PubMed. 32(3). 182–8. 2 indexed citations

10.

Chandrasekar, Pranatharthi, et al.. (1984). Enterococcal superinfection and colonization with aztreonam therapy. Antimicrobial Agents and Chemotherapy. 26(2). 280–282. 35 indexed citations

11.

Bonventre, Peter F., Calvin C. Linnemann, Lana S. Weckbach, et al.. (1984). Antibody Responses To Toxic-Shock-Syndrome (TSS) Toxin by Patients with TSS and by Healthy Staphylococcal Carriers. The Journal of Infectious Diseases. 150(5). 662–666. 69 indexed citations

12.

Smith, B R, et al.. (1983). Cefmenoxime penetration into gallbladder bile and tissue. Antimicrobial Agents and Chemotherapy. 23(6). 941–943. 4 indexed citations

13.

LeFrock, Jack L., et al.. (1983). In-vitro and in-vivo comparison of mezlocillin and cefoxitin. Journal of Antimicrobial Chemotherapy. 11(suppl C). 83–90. 5 indexed citations

14.

LeFrock, Jack L., et al.. (1982). Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections. Journal of Antimicrobial Chemotherapy. 10(suppl C). 215–221. 5 indexed citations

15.

LeFrock, Jack L., et al.. (1982). Comparative clinical evaluation of mezlocillin and cefoxitin. Journal of Antimicrobial Chemotherapy. 9(suppl A). 199–203. 11 indexed citations

16.

Smith, B R, et al.. (1953). BLEPHAROPTOSIS TREATED BY THE FRIEDENWALD-GUYTON SUTURE. Archives of Ophthalmology. 49(1). 45–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact